Cummings, J. L., & Frölich, L. (2012). Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease. Dementia and geriatric cognitive disorders, 33(5), .
Chicago-Zitierstil (17. Ausg.)Cummings, Jeffrey L., und Lutz Frölich. "Randomized, Double-blind, Parallel-group, 48-week Study for Efficacy and Safety of a Higher-dose Rivastigmine Patch (15 Vs. 10 Cm(2)) in Alzheimer's Disease." Dementia and Geriatric Cognitive Disorders 33, no. 5 (2012).
MLA-Zitierstil (9. Ausg.)Cummings, Jeffrey L., und Lutz Frölich. "Randomized, Double-blind, Parallel-group, 48-week Study for Efficacy and Safety of a Higher-dose Rivastigmine Patch (15 Vs. 10 Cm(2)) in Alzheimer's Disease." Dementia and Geriatric Cognitive Disorders, vol. 33, no. 5, 2012.